KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Income from Non-Controlling Interests (2016 - 2019)

Historic Income from Non-Controlling Interests for CRISPR Therapeutics AG (CRSP) over the last 5 years, with Q1 2019 value amounting to $14.2 million.

  • CRISPR Therapeutics AG's Income from Non-Controlling Interests rose 1360.0% to $14.2 million in Q1 2019 from the same period last year, while for Mar 2019 it was $54.4 million, marking a year-over-year increase of 2592.59%. This contributed to the annual value of $52.5 million for FY2018, which is 4502.76% up from last year.
  • As of Q1 2019, CRISPR Therapeutics AG's Income from Non-Controlling Interests stood at $14.2 million, which was up 1360.0% from $14.1 million recorded in Q4 2018.
  • CRISPR Therapeutics AG's Income from Non-Controlling Interests' 5-year high stood at $14.2 million during Q1 2019, with a 5-year trough of -$16000.0 in Q4 2015.
  • Its 5-year average for Income from Non-Controlling Interests is $6.9 million, with a median of $9.0 million in 2017.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first crashed by 130000.0% in 2016, then surged by 115010000.0% in 2017.
  • CRISPR Therapeutics AG's Income from Non-Controlling Interests (Quarter) stood at -$16000.0 in 2015, then skyrocketed by 93.75% to -$1000.0 in 2016, then soared by 1150100.0% to $11.5 million in 2017, then increased by 22.61% to $14.1 million in 2018, then grew by 0.71% to $14.2 million in 2019.
  • Its Income from Non-Controlling Interests stands at $14.2 million for Q1 2019, versus $14.1 million for Q4 2018 and $12.6 million for Q3 2018.